Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |